标题
A systemic review of taxanes and their side effects in metastatic breast cancer
作者
关键词
-
出版物
Frontiers in Oncology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-10-11
DOI
10.3389/fonc.2022.940239
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Persistent taxane‐induced neuropathy in elderly patients treated for localized breast cancer
- (2020) Lucile Pabst et al. Breast Journal
- Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)
- (2019) T Bachelot et al. ANNALS OF ONCOLOGY
- Patient‐reported and clinician‐reported chemotherapy‐induced peripheral neuropathy in patients with early breast cancer: Current clinical practice
- (2019) Kirsten A. Nyrop et al. CANCER
- Tumor-Associated Neutrophils in Cancer: Going Pro
- (2019) Wu et al. Cancers
- Chemotherapy-Induced Neutropenia as a Prognostic and Predictive Marker of Outcomes in Solid-Tumor Patients
- (2018) Pashtoon Murtaza Kasi et al. DRUGS
- Timing of chemotherapy-induced neutropenia: the prognostic factor in advanced pancreatic cancer patients treated with gemcitabine / gemcitabine-based chemotherapy
- (2017) Yang Chen et al. Oncotarget
- Incidence and Mortality and Epidemiology of Breast Cancer in the World
- (2016) Mahshid Ghoncheh et al. Asian Pacific Journal of Cancer Prevention
- Severe neutropenia during cabazitaxel treatment is associated with survival benefit in men with metastatic castration-resistant prostate cancer (mCRPC): A post-hoc analysis of the TROPIC phase III trial
- (2016) Alexander Meisel et al. EUROPEAN JOURNAL OF CANCER
- Exploring patient- and physician-related factors preventing breast cancer patients from guideline-adherent adjuvant chemotherapy—results from the prospective multi-center study BRENDA II
- (2016) Lukas Schwentner et al. SUPPORTIVE CARE IN CANCER
- Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
- (2015) Sandra M. Swain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Taxanes enhance trastuzumab-mediated ADCC on tumor cells through NKG2D-mediated NK cell recognition
- (2015) Martina Di Modica et al. Oncotarget
- Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology
- (2014) Jean-Pierre Droz et al. LANCET ONCOLOGY
- Awareness of the adverse effects associated with prophylactic corticosteroid use during docetaxel therapy
- (2014) Ka-Eun Yoo et al. SUPPORTIVE CARE IN CANCER
- Presentation and management of docetaxel-related adverse effects in patients with breast cancer
- (2014) Maria Ho et al. Cancer Management and Research
- Definitive Results of a Phase III Adjuvant Trial Comparing Three Chemotherapy Regimens in Women With Operable, Node-Positive Breast Cancer: The NSABP B-38 Trial
- (2013) Sandra M. Swain et al. JOURNAL OF CLINICAL ONCOLOGY
- 2-weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: a randomised, phase 3 trial
- (2013) Pirkko-Liisa Kellokumpu-Lehtinen et al. LANCET ONCOLOGY
- Hypersensitivity reaction studies of a polyethoxylated castor oil-free, liposome-based alternative paclitaxel formulation
- (2013) HONGBO WANG et al. Molecular Medicine Reports
- Phase III Trial Evaluating Weekly Paclitaxel Versus Docetaxel in Combination With Capecitabine in Operable Breast Cancer
- (2012) Catherine M. Kelly et al. JOURNAL OF CLINICAL ONCOLOGY
- Cimetidine enhances delayed-type hypersensitivity responses and serum interleukin (IL)-2, -10, -12, and IL-17 levels after burn injury in an animal model
- (2012) A. Jafarzadeh et al. Journal of Immunotoxicology
- Weekly docetaxel in metastatic breast cancer patients: No superior benefits compared to three-weekly docetaxel
- (2011) Carolien P. Schröder et al. EUROPEAN JOURNAL OF CANCER
- Complement activation by polyethoxylated pharmaceutical surfactants: Cremophor-EL, Tween-80 and Tween-20
- (2011) Zsóka Weiszhár et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Prospective Multicenter Randomized Phase III Study of Weekly versus Standard Docetaxel (D2) for First-Line Treatment of Metastatic Breast Cancer
- (2011) Hans-Joachim Stemmler et al. ONCOLOGY
- Intravenous therapies for castration-resistant prostate cancer: Toxicities and adverse events
- (2011) Eric A. Singer et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Dexamethasone premedication for prophylaxis of taxane toxicities: Can the doses be reduced when paclitaxel or docetaxel are given weekly?
- (2011) Joanna R Schwartz JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Meta-analysis of neutropenia or leukopenia as a prognostic factor in patients with malignant disease undergoing chemotherapy
- (2010) Kohei Shitara et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Longer Therapy, Iatrogenic Amenorrhea, and Survival in Early Breast Cancer
- (2010) Sandra M. Swain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Single premedication dose of dexamethasone 20 mg IV before docetaxel administration
- (2010) Jyoti D Chouhan et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Phase 3 study comparing the use of docetaxel on an every-3-week versus weekly schedule in the treatment of metastatic breast cancer
- (2008) Edgardo Rivera et al. CANCER
- Gemcitabine Plus Paclitaxel Versus Paclitaxel Monotherapy in Patients With Metastatic Breast Cancer and Prior Anthracycline Treatment
- (2008) Kathy S. Albain et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer and Leukemia Group B Protocol 9840
- (2008) Andrew D. Seidman et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Weekly Dose-Dense Paclitaxel in Extensive-Stage Small Cell Lung Cancer: Cancer and Leukemia Group B Study 39901
- (2008) Stephen L. Graziano et al. Journal of Thoracic Oncology
- Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer
- (2008) Joseph A. Sparano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials
- (2007) Michele De Laurentiis et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started